Imatinib Mesylate is used to treat and prevent the growth of certain types of cancers of the blood cells, stomach, intestine, bone marrow, and skin.
USE:
Chronic myelogenous leukemia (CML), Acute lymphoblastic Leukemia (ALL), Myeloproliferative disorder, Myelodysplastic disease, Systemic mastocytosis, Hypereosinophillic syndrome, Chronic eosinophillic leukemia,Dermatofibrosarcoma protuberans,Gastrointestinal stromal tumor